CTCs
Advanced Genomics APAC, CancerFree Biotech Partner to Combine NGS, Drug Response Testing
The firms will bring together Advanced Genomics APAC's genomic profiling workflow and CancerFree Biotech's in vitro drug screening technology.
Angle Raises $630K in Open Offer of Shares
The company said the proceeds will strengthen its balance sheet as it works to advance its circulating tumor cell platform for diagnostics and drug development.
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
The company will use its Parsortix platform to develop a circulating tumor cell-based assay to measure androgen receptor status in therapy response.
Angle Inks Assay Development Deal with AstraZeneca
The company is working to tailor its existing circulating tumor cell DNA damage response assay for use in pharmaceutical R&D.
Circulating Tumor Cell Capture Chip Could Help Predict Therapy Benefit in Lung Cancer Patients
Premium
The new microfluidic chip is designed to capture more circulating tumor cells in patients with non-small cell lung cancer than currently available technologies.
Feb 23, 2023
Oct 31, 2022
Aug 18, 2021
May 27, 2021
Mar 31, 2021
Mar 31, 2021